Should You Buy Bioventus Inc (BVS) Today? Analysis, Price Targets, and 2026 Outlook.
No data
No data
Growth
Profitability
Efficiency
Wall Street analysts forecast BVS.O stock price to rise
2 Analyst Rating
Wall Street analysts forecast BVS.O stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 9.150
Low
13
Averages
14
High
15
Current: 9.150
Low
13
Averages
14
High
15
CJS Securities
Lawrence Solow
Outperform
initiated
$14
AI Analysis
2026-03-27
Reason
CJS Securities
Lawrence Solow
Price Target
$14
AI Analysis
2026-03-27
initiated
Outperform
Reason
CJS Securities analyst Lawrence Solow initiated coverage of Bioventus with an Outperform rating and $14 price target.
Barrington
NULL -> Outperform
maintain
$13 -> $14
2026-03-06
Reason
Barrington
Price Target
$13 -> $14
2026-03-06
maintain
NULL -> Outperform
Reason
Barrington raised the firm's price target on Bioventus to $14 from $13 and keeps an Outperform rating on the shares. The firm cites the company's "strong" Q4 report and better than expected fiscal 2026 outlook for the target boost.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for BVS.O
